Tesla SpaceX IPO +2.6%: Why the Listing Could Shake TSLA
Could a SpaceX listing unlock Musk’s empire value while pulling fresh momentum money away from Tesla at the same time?
AbbVie MAVIRET Approval Gets EMA Backing for Acute HCV
Could AbbVie’s latest MAVIRET milestone become another quiet growth lever as investors look beyond its biggest blockbuster franchises?
IBM Quantum Funding $1B Boosts Stock on Foundry Bet
Can IBM Quantum Funding turn a government-backed $1 billion award into a real growth engine for the stock?
Spotify AI Strategy +6.6% as 2030 Billion-User Plan Lifts Shares
Can Spotify’s AI push and billion-user ambition finally convince investors that the streaming giant deserves a much higher valuation?
Ross Stores Earnings Jump +7.1% as Outlook Hits Record High
Did Ross Stores just prove bargain retail is still one of the strongest plays in a selective consumer market?
AMD AI Strategy +5.8% as Server Growth Fuels Optimism
Can AMD’s AI push in servers and Taiwan turn today’s rally into a longer-term challenge to Intel and Nvidia?
BioNTech Oncology Faces $1B Buyback Warning Before ASCO
Can BioNTech Oncology turn its huge cash pile into a real cancer breakthrough before investors lose patience?
Take-Two GTA 6 Launch: $8.1B Outlook Jumps After Date
Has Take-Two finally removed the biggest risk hanging over GTA 6, or is the real test only beginning now?
Micron Forecast +4.1% as AI Memory Boom Lifts MU Outlook
Can Micron’s AI-fueled memory surge keep pushing MU higher, or is Wall Street getting ahead of the cycle?
NIO Earnings 112% Surge as Q1 Margins Rebound Strongly
Can NIO turn one strong quarter into a real comeback, or is China’s EV price war still the bigger story?